Company / Current Liabilities
Biogen Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$3.3B
FY2025
5-year range
$3.3B / $5.5B
FY2021-FY2025
Trend
-39.4%
vs FY2024
Sector context
#14 of 215
Health Care
What the data says
Among 215 Health Care companies, Biogen is in the bottom 7% for current liabilities. Current Liabilities has fluctuated over the past 10 years, ranging from $3.3B in FY2022 to $5.5B in FY2024.
Based on SEC 10-K filings.
$3.3B in FY2025 with a 5-year CAGR of -2.2%. Top quartile in the Health Care sector.
Improved from $3.4B to $3.3B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- -2.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 215This company $3.3B Sector average $1.6B
▼
+112.7% above sector average
Key checks
Key Insights
- 5-year CAGR of -2.2%, indicating a declining trend.
- In FY2025, current liabilities decreased 39.4% year-over-year.
- Ranks #14 out of 215 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.3B | -39.4% |
| FY2024 | $5.5B | +61.0% |
| FY2023 | $3.4B | +4.9% |
| FY2022 | $3.3B | -23.9% |
| FY2021 | $4.3B | +14.9% |
| FY2020 | $3.7B | -23.1% |
| FY2019 | $4.9B | +47.6% |
| FY2018 | $3.3B | -2.2% |
| FY2017 | $3.4B | -1.5% |
| FY2016 | $3.4B | +32.7% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026